Weiyan Medical

WillingMed Technology (Beijing) Co., Ltd., operating as Weiyan Medical, was established in 2019 by a team with extensive experience in pathogen detection. The founders, including CEO Zhang Yan and CTO Dr. Gai Wei, have backgrounds from institutions like Tsinghua University and the Chinese Academy of Sciences and have been deeply involved in the field for nearly two decades. Dr. Zhang has a long history in R&D and clinical application of advanced technologies, while Dr. Gai has focused on the precise molecular diagnosis of infectious pathogens for over a decade. Their collective experience in in-vitro diagnostic product development and management spurred the creation of Weiyan Medical to address challenges in clinical infection diagnostics.

The company operates in the precision molecular diagnostics market, specifically targeting infectious diseases. Its primary clients are large-scale hospitals, serving departments such as infectious diseases, respiratory, pediatrics, and intensive care units (ICU). Weiyan Medical generates revenue by providing diagnostic services and products, including the development, production, and sale of reagent kits and automated equipment. The business integrates scientific research, medical testing, and equipment manufacturing, with several regional testing centers in cities like Beijing, Hangzhou, and Guangzhou.

Weiyan Medical's core offering revolves around metagenomic next-generation sequencing (mNGS) to identify a wide array of pathogens from clinical samples. A key product is the PIseq-pathogen metagenome detection service, which can identify over 24,000 types of microorganisms, including bacteria, fungi, and viruses, delivering reports within 20 hours. For respiratory samples, the company developed a combined DNA+RNA pathogen detection process, which helps reduce testing costs. For more challenging blood samples, they introduced a highly sensitive dual-dimension blood infection detection product. To streamline the complex mNGS workflow, Weiyan Medical offers the WYHAW High-Throughput Automatic Workstation, a system designed to automate the entire process from sample preparation and library construction to data analysis and report generation, thereby reducing manual labor and improving safety and efficiency in clinical labs.

Keywords: pathogen detection, molecular diagnostics, infectious diseases, metagenomic next-generation sequencing, mNGS, clinical diagnostics, IVD, DNA sequencing, RNA sequencing, microbial detection, blood infection testing, respiratory pathogen testing, automated laboratory workstation, bioinformatics, medical testing services, reagent manufacturing, clinical laboratory, precision medicine, pathogen identification, genomic analysis